Risk factors and outcomes in lung transplant recipients with nodular invasive pulmonary aspergillosis

被引:20
作者
Singh, Nina [1 ]
Suarez, Jose F. [2 ]
Avery, Robin [3 ]
Lass-Floerl, Cornelia [4 ]
Geltner, Christian [4 ]
Pasqualotto, Alessandro C. [5 ]
Lyon, G. Marshall [6 ]
Barron, Michelle [7 ]
Husain, Shahid [8 ]
Wagener, Marilyn M. [1 ]
Montoya, Jose G. [2 ]
机构
[1] Univ Pittsburgh, Pittsburgh, PA USA
[2] Stanford Univ, Palo Alto, CA 94304 USA
[3] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[4] Med Univ Innsbruck, A-6020 Innsbruck, Austria
[5] UFCSPA, Porto Alegre, RS, Brazil
[6] Emory Univ, Atlanta, GA 30322 USA
[7] Univ Colorado, Denver, CO 80202 USA
[8] Univ Toronto, Toronto, ON, Canada
关键词
Aspergillosis; Lung transplant; Transplant; Lung nodules; CT MANIFESTATIONS; AMPHOTERICIN-B; INFECTIONS; CRYPTOCOCCOSIS; VORICONAZOLE; RECOMMENDATIONS; DISEASES;
D O I
10.1016/j.jinf.2013.03.013
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Whether nodular lesions have specific risk-factors or influence outcomes in lung transplant recipients with invasive aspergillosis, is not fully known. Methods: The study population consisted of 64 consecutive lung transplant recipients with proven or probable invasive aspergillosis. Nodules, with or without halo/air crescent-sign were considered nodular presentations. Outcomes assessed were response rate (successful versus unsuccessful outcome) and all-cause mortality at 12 weeks. Results: Overall, 34 patients had nodular and 30 had non-nodular lesions. Presence of nodular lesions was less likely to be associated with renal failure at baseline (adjusted OR 0.21, 95% CI, 0.04-0.97, p=0.047), CMV infection (adjusted OR 0.18, 95% CI 0.04-0.75, p=0.019) and receipt of antifungal prophylaxis (adjusted OR 0.22,95% CI, 0.06-0.88, p=0.032). Successful outcome and mortality rates in the study patients were 64.0% (41/64) and 25.0% (16/64), respectively. Nodular aspergillosis was associated with significantly higher successful outcome (adjusted OR 3.35, 95% CI, 1.06-10.54, p=0.039) and lower mortality at 12 weeks (adjusted OR 0.20, 0.05-0.78, p=0.021). Conclusions: Lung transplant recipients with nodular lesions due to invasive aspergillosis had better outcomes than those without such lesions. (C) 2013 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:72 / 78
页数:7
相关论文
共 27 条
  • [1] The impact of invasive fungal diseases on survival after lung transplantation
    Arthurs, Supha K.
    Eid, Albert J.
    Deziel, Paul J.
    Marshall, William F.
    Cassivi, Stephen D.
    Walker, Randall C.
    Razonable, Raymund R.
    [J]. CLINICAL TRANSPLANTATION, 2010, 24 (03) : 341 - 348
  • [2] Glossary of terms for CT of the lungs: Recommendations of the Nomenclature Committee of the Fleischner Society
    Austin, JHM
    Muller, NL
    Friedman, PJ
    Hansell, DM
    Naidich, DP
    RemyJardin, M
    Webb, WR
    Zerhouni, EA
    [J]. RADIOLOGY, 1996, 200 (02) : 327 - 331
  • [3] Antifungal Prophylaxis in Lung Transplantation
    Avery, Robin K.
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 32 (06) : 717 - 726
  • [4] Factors Associated with Mortality in Transplant Patients with Invasive Aspergillosis
    Baddley, John W.
    Andes, David R.
    Marr, Kieren A.
    Kontoyiannis, Dimitrios P.
    Alexander, Barbara D.
    Kauffman, Carol A.
    Oster, Robert A.
    Anaissie, Elias J.
    Walsh, Thomas J.
    Schuster, Mindy G.
    Wingard, John R.
    Patterson, Thomas F.
    Ito, James I.
    Williams, O. Dale
    Chiller, Tom
    Pappas, Peter G.
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 50 (12) : 1559 - 1567
  • [5] CAMERON ML, 1991, REV INFECT DIS, V13, P64
  • [6] Casadevall A, 1998, CRYPTOCOCCUS NEOFORM, P271
  • [7] Clinical and radiologic factors associated with pulmonary nodule etiology in organ transplant recipients
    Copp, D. H.
    Godwin, J. D.
    Kirby, K. A.
    Limaye, A. P.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (11) : 2759 - 2764
  • [8] Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
    De Pauw, Ben
    Walsh, Thomas J.
    Donnelly, J. Peter
    Stevens, David A.
    Edwards, John E.
    Calandra, Thierry
    Pappas, Peter G.
    Maertens, Johan
    Lortholary, Olivier
    Kauffman, Carol A.
    Denning, David W.
    Patterson, Thomas F.
    Maschmeyer, Georg
    Bille, Jacques
    Dismukes, William E.
    Herbrecht, Raoul
    Hope, William W.
    Kibbler, Christopher C.
    Kullberg, Bart Jan
    Marr, Kieren A.
    Munoz, Patricia
    Odds, Frank C.
    Perfect, John R.
    Restrepo, Angela
    Ruhnke, Markus
    Segal, Brahm H.
    Sobel, Jack D.
    Sorrell, Tania C.
    Viscoli, Claudio
    Wingard, John R.
    Zaoutis, Theoklis
    Bennett, John E.
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 46 (12) : 1813 - 1821
  • [9] Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: Implications for assessment of tumor response
    Erasmus, JJ
    Gladish, GW
    Broemeling, L
    Sabloff, BS
    Truong, MT
    Herbst, RS
    Munden, RF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (13) : 2574 - 2582
  • [10] Comparative cost-effectiveness of voriconazole and amphotericin B in treatment of invasive pulmonary aspergillosis
    Greene, Reginald E.
    Mauskopf, Josephine
    Roberts, Craig S.
    Zyczynski, Teresa
    Schlamm, Haran T.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (24) : 2561 - 2568